Levosimendan: a review of its use in the management of acute decompensated heart failure.
about
When sepsis affects the heart: A case report and literature review.Effects of the calcium sensitizer OR-1896, a metabolite of levosimendan, on post-infarct heart failure and cardiac remodelling in diabetic Goto-Kakizaki ratsDual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardiumAmlodipine poisioning complicated with acute non-cardiogenic pulmonary oedema.Myocardial regulatory proteins and heart failure.Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan.Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.The effect of levosimendan in rat mesenteric ischemia/reperfusion injury.Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
P2860
Q33425378-2A7E29B6-0BD7-41F4-9780-ECFC8A64AE57Q33812788-C3FAEE61-F1A8-47C5-8447-B8E08AF4C0D8Q35049090-048C5834-9F7A-457A-A7D4-0F0A91A930FEQ35222233-63C75D83-D9D4-4249-BE31-D8AE2E9F5E9AQ36323149-3358F78B-1501-47E5-B9E8-98C21877EFA9Q37314355-83F94E2A-AC61-4B4D-BCFB-0A454947BFC3Q37435182-6B4E9413-6060-48AC-AD16-794DE7C1808CQ37607413-68473985-1806-4CD6-93E7-F93239471D41Q40964343-4141C68C-3CBD-4AE0-A3A0-0DE65DC04914Q41584823-80FC57B5-BBAE-4D01-8E28-53549EA69564Q46497134-81A60192-CF64-4457-89B0-3B416DF6A68DQ46955705-A4B3DE16-ECB0-40E0-86F4-390CB8872B8CQ47748898-C5AB16E2-2809-4187-A17C-67C5F3CB1F57Q48263954-EE0278CC-1C37-4BEC-AE6C-721EB3C1D4ECQ53238556-733F8F1B-E314-4ED1-A749-A910CB98F5F8
P2860
Levosimendan: a review of its use in the management of acute decompensated heart failure.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@ast
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@en
type
label
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@ast
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@en
prefLabel
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@ast
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@en
P1433
P1476
Levosimendan: a review of its use in the management of acute decompensated heart failure.
@en
P2093
Carmen A Innes
P304
P356
10.2165/00003495-200363230-00009
P577
2003-01-01T00:00:00Z
P6179
1032420314